Driehaus Capital Management LLC Cerus Corp Transaction History

Driehaus Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$4.51 - $6.6 $2.48 Million - $3.64 Million	-550,837 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$5.16 - $6.85 $131,512 - $174,585	-25,487 Reduced 4.42%	550,837 $3.43 Million
Q4 2018 Feb 14, 2019	SELL	$4.89 - $7.16 $3.88 Million - $5.68 Million	-793,616 Reduced 57.93%	576,324 $2.92 Million
Q3 2018 Nov 14, 2018	BUY	$6.89 - $7.78 $25,107 - $28,350	3,644 Added 0.27%	1,369,940 $9.88 Million
Q2 2018 Aug 14, 2018	BUY	$5.19 - $7.25 $2.57 Million - $3.59 Million	495,618 Added 56.92%	1,366,296 $9.11 Million
Q1 2018 May 15, 2018	BUY	$3.56 - $5.74 $3.1 Million - $5 Million	870,678 New	870,678 $4.77 Million

156

147M

84.2K

55.5K

Ticker CERS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 177,090,000
Market Cap $331M
Description
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...

Get notified when there are updates to the investment portfolio of Driehaus Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Driehaus Capital Management LLC with notifications on news.